Published in Blood Weekly, February 20th, 1995
Ted Koster, M.D., University Hospital Leiden, and colleagues performed a population-based patient-control study in order to clarify the roles of the ABO blood group, von Willebrand factor (vWF) and clotting factor VIII in the process of deep-vein thrombosis ("Role of Clotting Factor VIII in Effect of von Willebrand Factor on Occurrence of Deep-Vein Thrombosis," the Lancet, January 21, 1995;345:152-155).
The researchers compared 301 consecutive patients under 70 years of age with a first diagnosed episode of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.